Published May 17, 2023 | Version 1.1
Dataset Open

Neutrophil and emergency granulopoietic drivers of sepsis immune suppression and an extreme response to infection

  • 1. Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford; Oxford, UK
  • 2. Wellcome Sanger Institute, Wellcome Genome Campus; Cambridge, UK
  • 3. Kennedy Institute of Rheumatology, University of Oxford; Oxford, UK
  • 4. John Radcliffe Hospital, Oxford Universities Hospitals NHS Foundation Trust; Oxford, UK
  • 5. William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University; London, UK

Description

The dysregulated host response to infection leading to organ dysfunction is highly heterogeneous. It is currently poorly delineated by sepsis as a clinical syndromic classification, thus confounding immunotherapy trials. Here we establish the pathophysiology and potential therapeutic targets of a specific extreme response to infection state (sepsis response signature SRS1), characterised by immune compromise and poor outcome. We first derive a whole blood single-cell multi-omic atlas of the sepsis response (2727,993 cells, n=39), finding an increase in IL1R2+ immature neutrophils in SRS1, which we confirmed by CyTOF and RNA-sequencing (n=53). We next uncovered high activity of neutrophil STAT3 gene expression programs in SRS1, which were shared across multiple infectioius disease settings (n=1044) irrespective of the clinical definition of the patient cohorts. We observed elevated plasma G-CSF and IL-6 in SRS1, suggesting heightened emergency granulopoiesis (EG). We therefore characterised patient and healthy control hematopoietic stem cells (HSCs) using single-cell RNA/chromatin accessibility multi-omics (29,366 cells, n=27), identifying SRS1-specific EG transcriptional skewing, together with STAT3 and EG master regulator CEBPB epigenetic signatures. Our findings establish a common cellular axis present across extreme responses to infection, reveal its hematopoietic origin, and nominate G-CSF and IL-6 as potential therapeutic targets for the SRS1 state.

 

The present data deposit includes processed and quality-controlled data tables for:

1. Whole blood leukocytes profiled with the BD Rhapsody platform in a cohort of 39 sepsis patients (RNA and protein count matrices, as well as their accompanying metadata table)

2. Circulating HSCs in blood profiled with the 10X multiomics platform in a cohort of 27 sepsis patients (RNA and ATAC-seq count matrices, as well as their accompanying metadata tables)

 

IMPORTANT NOTE: The files in Version 1.0 are incomplete (missing the cell barcode list and gene/feature names).
Please download Version 1.1 for the complete package (includes barcode and feature list files aligned to the matrices).

Files

Files (9.8 GB)

Name Size Download all
md5:6f9c371f891af0da01b6370690f1e948
3.3 GB Download
md5:a489c861f4d7199a2a134adea12df67d
997.4 kB Download
md5:769f4e6637346e2af0d005377674e0e9
12.9 MB Download
md5:75fca504f8516a8468b66318da596558
10.3 MB Download
md5:9e63c57f4315233a29e6814f969f65a5
2.7 GB Download
md5:a489c861f4d7199a2a134adea12df67d
997.4 kB Download
md5:0eb5a2d637b4a06943f5a412d717df5f
213.3 kB Download
md5:75fca504f8516a8468b66318da596558
10.3 MB Download
md5:0f23f383d7bc3b317b7f4cd80ba5741a
55.4 MB Download
md5:9812e0d17d1a25c2b65006edfc068e86
9.3 MB Download
md5:e07f50394e72a7aebd122a2a0c58e666
340 Bytes Download
md5:3c71e9e7947bd8a5b962b4d4a7ba4664
151.5 MB Download
md5:719ef6a602474e78c2331e39be9bee02
3.5 GB Download
md5:9812e0d17d1a25c2b65006edfc068e86
9.3 MB Download
md5:f927042500a6b4e9f3e4344b87815626
177.7 kB Download

Additional details

Related works

Cites
Preprint: 10.1101/2022.03.22.22272723 (DOI)

Funding

Wellcome Trust
Understanding the genetic basis of common human diseases: core funding for the Wellcome Trust Centre for Human Genetics. 090532
Wellcome Trust
Characterising extreme innate immune response phenotypes informative for disease using a functional genomics approach 204969
Wellcome Trust
Wellcome Trust Sanger Institute - generic account for deposition of all core- funded research papers. 206194
UK Research and Innovation
Investigation of the hyporesponsive endotype to inform a precision medicine approach to sepsis MR/V002503/1